Cost-effectiveness of dopamine agonists and monoamine oxidase B inhibitors in early Parkinson's disease

PD Med Collaborative Group

Research output: Contribution to journalArticlepeer-review

140 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Cost-effectiveness of dopamine agonists and monoamine oxidase B inhibitors in early Parkinson's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences